Several studies have reported the inhibition of metastasis of human MDA-MB-231 breast cancer cells in SCID mice using anti-CXCR4 antibodies [4,15], siRNA [8,16] or peptide antagonists of CXCR4 [10,15]. This evidence concerns the gene CXCR4 and breast carcinoma.